vs
亚玛芬体育（AS）与Astrana Health, Inc.（ASTH）财务数据对比。点击上方公司名可切换其他公司
亚玛芬体育的季度营收约是Astrana Health, Inc.的1.1倍（$1.1B vs $950.5M），亚玛芬体育净利率更高（1.8% vs 0.7%，领先1.1%），亚玛芬体育自由现金流更多（$92.2M vs $-6.0M）
亚玛芬体育是芬兰跨国运动装备企业，总部位于赫尔辛基，成立于1950年。早年为涉足烟草贸易、航运、出版等领域的多元化工业集团，后逐步转型专注于体育用品的生产与营销，现有员工超9700人，2018年起成为中国安踏体育旗下子公司。
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
AS vs ASTH — 直观对比
营收规模更大
AS
是对方的1.1倍
$950.5M
净利率更高
AS
高出1.1%
0.7%
自由现金流更多
AS
多$98.2M
$-6.0M
损益表 — Q1 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $950.5M |
| 净利润 | $19.0M | $6.6M |
| 毛利率 | 52.8% | — |
| 营业利润率 | 12.4% | 1.9% |
| 净利率 | 1.8% | 0.7% |
| 营收同比 | — | 42.9% |
| 净利润同比 | — | 184.4% |
| 每股收益（稀释后） | $0.05 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASASTH
| Q4 25 | — | $950.5M | ||
| Q3 25 | — | $956.0M | ||
| Q2 25 | — | $654.8M | ||
| Q1 25 | — | $620.4M | ||
| Q4 24 | — | $665.2M | ||
| Q3 24 | — | $478.7M | ||
| Q2 24 | — | $486.3M | ||
| Q1 24 | $1.1B | $404.4M |
净利润ASASTH
| Q4 25 | — | $6.6M | ||
| Q3 25 | — | $373.0K | ||
| Q2 25 | — | $9.4M | ||
| Q1 25 | — | $6.7M | ||
| Q4 24 | — | $-7.8M | ||
| Q3 24 | — | $16.1M | ||
| Q2 24 | — | $19.2M | ||
| Q1 24 | $19.0M | $14.8M |
毛利率ASASTH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 52.8% | — |
营业利润率ASASTH
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 3.1% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 6.2% | ||
| Q1 24 | 12.4% | 7.5% |
净利率ASASTH
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 3.9% | ||
| Q1 24 | 1.8% | 3.7% |
每股收益（稀释后）ASASTH
| Q4 25 | — | $0.12 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.19 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $0.33 | ||
| Q2 24 | — | $0.40 | ||
| Q1 24 | $0.05 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $429.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $779.3M |
| 总资产 | — | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASASTH
| Q4 25 | — | $429.5M | ||
| Q3 25 | — | $463.4M | ||
| Q2 25 | — | $342.1M | ||
| Q1 25 | — | $260.9M | ||
| Q4 24 | — | $290.8M | ||
| Q3 24 | — | $350.3M | ||
| Q2 24 | — | $327.7M | ||
| Q1 24 | — | $337.3M |
股东权益ASASTH
| Q4 25 | — | $779.3M | ||
| Q3 25 | — | $775.5M | ||
| Q2 25 | — | $765.5M | ||
| Q1 25 | — | $745.4M | ||
| Q4 24 | — | $712.7M | ||
| Q3 24 | — | $704.6M | ||
| Q2 24 | — | $678.9M | ||
| Q1 24 | — | $653.5M |
总资产ASASTH
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.3M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | $92.2M | $-6.0M |
| 自由现金流率自由现金流/营收 | 8.8% | -0.6% |
| 资本支出强度资本支出/营收 | 2.1% | 0.3% |
| 现金转化率经营现金流/净利润 | 6.02× | -0.44× |
| 过去12个月自由现金流最近4个季度 | — | $104.5M |
8季度趋势，按日历期对齐
经营现金流ASASTH
| Q4 25 | — | $-2.9M | ||
| Q3 25 | — | $10.0M | ||
| Q2 25 | — | $90.9M | ||
| Q1 25 | — | $16.6M | ||
| Q4 24 | — | $-10.9M | ||
| Q3 24 | — | $34.0M | ||
| Q2 24 | — | $23.2M | ||
| Q1 24 | $114.3M | $6.0M |
自由现金流ASASTH
| Q4 25 | — | $-6.0M | ||
| Q3 25 | — | $7.4M | ||
| Q2 25 | — | $89.5M | ||
| Q1 25 | — | $13.6M | ||
| Q4 24 | — | $-13.5M | ||
| Q3 24 | — | $31.7M | ||
| Q2 24 | — | $20.4M | ||
| Q1 24 | $92.2M | $5.6M |
自由现金流率ASASTH
| Q4 25 | — | -0.6% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 13.7% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | -2.0% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | 8.8% | 1.4% |
资本支出强度ASASTH
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | 2.1% | 0.1% |
现金转化率ASASTH
| Q4 25 | — | -0.44× | ||
| Q3 25 | — | 26.69× | ||
| Q2 25 | — | 9.65× | ||
| Q1 25 | — | 2.48× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | 1.21× | ||
| Q1 24 | 6.02× | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AS
| Americas2 | $409.6M | 39% |
| EMEA1 | $356.9M | 34% |
| Greater China3 | $205.6M | 20% |
| Asia Pacific4 | $78.2M | 7% |
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
